Next Article in Journal
Biomarkers in Early Response to Brolucizumab on Pigment Epithelium Detachment Associated with Exudative Age-Related Macular Degeneration
Previous Article in Journal
Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success
 
 
Review

The Role of the Bisphenol A in Diabetes and Obesity

1
SONEV Research Group, School of Medicine and Health Sciences, Catholic University of Valencia San Vicente Mártir, C/Quevedo nº 2, 46001 Valencia, Spain
2
School of Medicine and Health Sciences, Catholic University of Valencia San Vicente Mártir, C/Quevedo nº 2, 46001 Valencia, Spain
*
Author to whom correspondence should be addressed.
Academic Editor: Manfredi Tesauro
Biomedicines 2021, 9(6), 666; https://doi.org/10.3390/biomedicines9060666
Received: 14 May 2021 / Revised: 4 June 2021 / Accepted: 8 June 2021 / Published: 10 June 2021
(This article belongs to the Section Molecular and Translational Medicine)
Bisphenol A is a compound commonly found in products meant for daily use. It was one of the first compounds to be identified as an endocrine disruptor that was capable of disrupting the endocrine system and producing very similar effects to those of metabolic syndrome. It has recently gained popularity in the scientific arena as a risk factor for obesity and diabetes due to its ability to imitate natural oestrogens and bind to their receptors. The aim was to study the possible relationship between the Bisphenol A endocrine disruptor with diabetes and obesity. The analysis of the articles allows us to conclude that Bisphenol A is an additional risk factor to consider in the development of diabetes and obesity, since it is capable of stimulating the hypertrophy of adipocytes and altering the endocrine system by mimicking the effects of the oestrogen molecule, since epidemiological studies carried out have suggested that the same disruptions seen in experimental studies on animals can be found in humans; however, despite many countries having developed policies to limit exposure to this disruptor in their populations, there is a lack of international agreement. Understanding its relationship with obesity and diabetes will help to raise awareness in the population and adopt public health campaigns to prevent exposure—especially among young people—to these substances. View Full-Text
Keywords: Bisphenol A; obesity; endocrine disruptor; glucose intolerance; insulin resistance Bisphenol A; obesity; endocrine disruptor; glucose intolerance; insulin resistance
Show Figures

Figure 1

MDPI and ACS Style

Pérez-Bermejo, M.; Mas-Pérez, I.; Murillo-Llorente, M.T. The Role of the Bisphenol A in Diabetes and Obesity. Biomedicines 2021, 9, 666. https://doi.org/10.3390/biomedicines9060666

AMA Style

Pérez-Bermejo M, Mas-Pérez I, Murillo-Llorente MT. The Role of the Bisphenol A in Diabetes and Obesity. Biomedicines. 2021; 9(6):666. https://doi.org/10.3390/biomedicines9060666

Chicago/Turabian Style

Pérez-Bermejo, Marcelino, Irene Mas-Pérez, and Maria Teresa Murillo-Llorente. 2021. "The Role of the Bisphenol A in Diabetes and Obesity" Biomedicines 9, no. 6: 666. https://doi.org/10.3390/biomedicines9060666

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop